FENC

Fennec Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↓ 2/10
  • Value↓ 1/10
Fennec Pharmaceuticals sales and earnings growth
FENC Growth
Fair
  • Revenue Y/Y↑ 32.05%
  • EPS Y/Y↑ 47.17%
  • FCF Y/Y↑ 64.75%
Fennec Pharmaceuticals gross and profit margin trends
FENC Profitability
Good
  • Gross margin ↑ 92.20%
  • EPS margin↓ -16.40%
  • ROIC 5Y↓ -19.98%
Fennec Pharmaceuticals net debt vs free cash flow
FENC Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -4.5

Fennec Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks